Avid Bioservices, Inc. (CDMO)
Fuera de horario:
Avid Bioservices, Inc.
14191 Myford Road
Tustin, CA 92780
United States
714-508-6100
https://www.avidbio.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 365
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Nicholas Stewart Green B.Sc., MBA | President, CEO & Director | 1.35M | N/D | 1965 |
| Mr. Daniel R. Hart | Chief Financial Officer | 719.75k | 33.35k | 1973 |
| Mr. Richard Richieri | Chief Operations Officer | 561.68k | N/D | 1965 |
| Mr. Mark R. Ziebell J.D. | VP, General Counsel & Corporate Secretary | 647.1k | 64.6k | 1964 |
| Mr. Matthew Kwietniak | Chief Commercial Officer | 553.59k | N/D | 1969 |
| Ms. Oksana Lukash | Vice President of People | N/D | N/D | N/D |
Descripción
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
Gestión corporativa
La calificación ISS Governance QuickScore de Avid Bioservices, Inc. a partir del 1 de mayo de 2024 es 5. Las puntuaciones principales son Auditoría: 10; Junta: 3; Derechos del accionista: 4; Compensación: 2.
